Nurse Practitioner in Cochranville, PA Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Mrs. Rachel Sweet Kramer, RN, MSN, MBA, NP Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 712 Bee Ridge Path, Cochranville, PA 19330 Phone: 717-317-7535 Fax: 916-357-8781 |
 Stephen Sparks, CRNP Nurse Practitioner - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 10 Homestead Ln, Cochranville, PA 19330 Phone: 610-406-2039 |
Mrs. Jamie Galli, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 81 Village Dr, Cochranville, PA 19330 Phone: 610-842-2440 |
News Archive
Columbian scientists tap global computer network in search of leishmaniasis drugs
"Colombian scientists are using a global network of personal and institutional computers to search for potential drugs against leishmaniasis, a disease that affects 12 million people worldwide," SciDev.Net reports. The researchers at the University of Antioquia "will harness the calculation potential of the almost two million computers that make up the World Community Grid, funded by the IBM Corporation," the news service writes.
Woman dies after being scratched by a wild rat
As a rule leptospirosis victims experience severe headaches and flu-like symptoms but the severe form which is Weil's disease, causes jaundice and liver damage, and can be fatal - but it usually only affects 10% of leptospirosis victims.
Researcher traces origins of double-trauma amnesia cure belief
Spiers, PhD, associate professor in the College of Arts and Sciences' Department of Psychology, traced the origins of the double-trauma amnesia cure belief in a paper for Neurology titled, "The Head Trauma Amnesia Cure: The Making of a Medical Myth."
Hard work of GPs pays off: high levels of patient satisfaction reported
Commenting on the publication of the 'Patient Experience Survey of GP and Local NHS Services 2011/12' results, Dr Dean Marshall, Chair of BMA Scotland's General Practice Committee said:
Merck reports results from global EMEND Phase 3 study for CINV prevention in pediatric cancer patients
Merck, known as MSD outside the United States and Canada, today announced results from a global, investigational Phase 3 study to evaluate the safety and efficacy of EMEND (aprepitant) in the prevention of chemotherapy-induced nausea and vomiting (CINV) in pediatric cancer patients, aged 6 months to 17 years.
› Verified 4 days ago